Summary
Overview
Work History
Education
Skills
Timeline
Generic

Elizabeth R. Bickler

Cross River,NY

Summary

Senior executive with proven track record in driving growth and operational excellence. Adept at strategic planning, project management, and leveraging data to inform decisions. Strong focus on fostering team collaboration and adapting to changing business needs. Highly skilled in leadership, communication, and delivering impactful results.

Overview

20
20
years of professional experience

Work History

Senior Director of Portfolio & Business Development

Xiromed USA
05.2022 - Current
  • Led launch management for over 80 pharmaceutical products across a broad range of dosage forms and therapeutic areas
  • Selected and prioritized development portfolio to drive growth of $200m business, growing at a 26% CAGR
  • Led portfolio and business development activities to maximize long-term value of commercial plan for pipeline of over 60 pharmaceutical products
  • Oversaw evaluation of product candidates, leveraging internal capabilities and optimizing competitive position in the market to maximize value for the business unit
  • Managed creation of long-term portfolio forecasts to align strategic goals with executive management and ownership
  • Oversaw R&D budgeting process, focused on maximizing pipeline productivity
  • Led creation of 5-year strategic plan to ensure long-term strategy alignment with global company goals
  • Generated leads on potential strategic acquisition targets and portfolio opportunities and managed negotiations
  • Led US due diligence and integration activities for $250m global acquisition, including portfolio of 45 products and 2 manufacturing sites
  • Negotiated business development partnerships for strategic projects to align on terms and maximize value to portfolio
  • Managed strategic alliances with co-development partners to ensure timely execution of development milestones
  • Managed partnerships with API vendors and negotiated price and terms to maximize margin potential
  • Led launch management process, including tracking critical cross-functional launch activities among sales, supply chain, regulatory affairs, quality, pharmacovigilance and business development to ensure successful execution of new product launches


Director of Portfolio

Xiromed USA
01.2015 - 04.2022
  • Established US generics business unit for global parent, Insud Pharma, and launched commercially within 2.5 years
  • Implemented budgeting, forecasting and financial modeling systems for R&D portfolio lifecycle from product selection through commercial launch
  • Conducted pipeline committee meetings to present new product ideas to executive management and ownership
  • Created long-term portfolio forecasts and presented quarterly to executive management
  • Created business cases including NPV analysis, ROIC and payback calculations to prioritize portfolio projects
  • Established annual R&D budget and revised latest estimates quarterly to maximize pipeline productivity
  • Collaborated with global finance, project management and R&D teams to set priorities and ensure pipeline progress
  • Worked with global and local internal BD teams to align US generics portfolio with global portfolio strategy
  • Developed systems and processes for the exchange of critical information among various functional groups including R&D, project management, clinical, IP and regulatory
  • Managed continuous market analysis, competitor analysis, cost analysis and pricing analysis for new opportunities and ongoing evaluation for current pipeline projects
  • Conducted due diligence and collaborated across functions including legal, regulatory, R&D and global BD teams to execute strategic product and company acquisitions
  • Collaborated with sales and commercial strategy teams on forecasting, pricing and customer targets for new launches
  • Created company press releases and collaborated on public relations committee to align on communications strategy
  • Managed execution of serialization and VRS implementation with serialization partner, Tracelink
  • Extensive experience with industry database tools that enable new product identification and analysis, including IQVIA (IMS), Wolters Kluwer, IPD Analytics, Evaluate Pharma, Medi Span, AnalySource, ProspectoRx, AlphaSense, SAP and Power BI

Strategic Pipeline Planning Manager

Perrigo Pharmaceuticals
08.2008 - 12.2014
  • Created and maintained financial models for Rx pipeline portfolio throughout product development lifecycle
  • Identified and analyzed new product candidates for development and maintained database of product opportunities
  • Directed R&D efforts for Rx division through ongoing project prioritization to meet target goals
  • Managed R&D project budget and prioritized budget allocation based on financing needs and strategic rationale
  • Analyzed and presented product recommendations to key decision makers in pipeline committee and Stage Gate forums
  • Performed product and competitor analysis for business development team to support decisions on partnerships
  • Identified targets and conducted due diligence on potential company and product portfolio acquisitions
  • Analyzed pipeline and commercial portfolios for Paddock Labs acquisition and played key role in post-acquisition integration activities
  • Supported branded Rx VP with product ideation, analysis and financial modeling
  • Created annual and 5-year business plans to support long term business growth
  • Identified and explored new product categories and technologies for potential in-house development
  • Collaborated cross-functionally to ensure transparency of information to update business of pipeline progress

Credit Derivatives Analyst

HSBC Bank, USA
01.2008 - 07.2008
  • Investigated trade discrepancies and reconciled client accounts to ensure proper settlement of obligations
  • Identified and quantified trade failures and reported to management
  • Analyzed trends in trade booking discrepancies and identified key issues to rectify process

Marketing Analyst

Plantex, USA
07.2005 - 05.2007
  • Investigated new API sales opportunities for 7-person sales force
  • Identified market trends to revise strategic positioning and developed marketing strategies for new API products
  • Created and edited presentations and marketing materials for sales representatives
  • Performed competitive analysis to anticipate shifts in the market and recommend positioning to sales force
  • Presented bi-monthly overviews of customers and product markets for sales force
  • Published annual work plan including product marketing strategy and 3-year sales projections

Customer Service Representative

Plantex, USA
12.2004 - 06.2005
  • Overhauled customer communication system to facilitate improved transparency for sales team and clients
  • Liaised with customers to implement strategic demand planning and managed allocation of scarce product

Education

Master’s in Business Administration - Concentration in Finance

New York University, Stern School of Business
New York, NY
01.2010

Bachelor of Arts - International Studies, Concentration in Economics, Minors in Spanish and German

American University, School of International Service
Washington, DC
01.2003

Skills

  • Strategic Planning
  • Portfolio Management
  • Business Development
  • Market Analysis
  • Business Case Creation & Comparison
  • Sales Growth Initiatives
  • M&A Project Coordination
  • Collaborative Team Management
  • Project Management
  • Life-Cycle Management
  • Budget Oversight
  • Risk Management Strategies

Timeline

Senior Director of Portfolio & Business Development

Xiromed USA
05.2022 - Current

Director of Portfolio

Xiromed USA
01.2015 - 04.2022

Strategic Pipeline Planning Manager

Perrigo Pharmaceuticals
08.2008 - 12.2014

Credit Derivatives Analyst

HSBC Bank, USA
01.2008 - 07.2008

Marketing Analyst

Plantex, USA
07.2005 - 05.2007

Customer Service Representative

Plantex, USA
12.2004 - 06.2005

Bachelor of Arts - International Studies, Concentration in Economics, Minors in Spanish and German

American University, School of International Service

Master’s in Business Administration - Concentration in Finance

New York University, Stern School of Business
Elizabeth R. Bickler